Carmela Mannarelli

3.3k total citations
27 papers, 1.1k citations indexed

About

Carmela Mannarelli is a scholar working on Genetics, Hematology and Molecular Biology. According to data from OpenAlex, Carmela Mannarelli has authored 27 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Genetics, 13 papers in Hematology and 10 papers in Molecular Biology. Recurrent topics in Carmela Mannarelli's work include Myeloproliferative Neoplasms: Diagnosis and Treatment (24 papers), Acute Myeloid Leukemia Research (11 papers) and Eosinophilic Disorders and Syndromes (10 papers). Carmela Mannarelli is often cited by papers focused on Myeloproliferative Neoplasms: Diagnosis and Treatment (24 papers), Acute Myeloid Leukemia Research (11 papers) and Eosinophilic Disorders and Syndromes (10 papers). Carmela Mannarelli collaborates with scholars based in Italy, United States and Switzerland. Carmela Mannarelli's co-authors include Paola Guglielmelli, Alessandro M. Vannucchi, Giada Rotunno, Tiziana Fanelli, Annalisa Pacilli, Alessandro Pancrazzi, Lisa Pieri, Alberto Bosi, Ayalew Tefferi and Naseema Gangat and has published in prestigious journals such as Blood, PLoS ONE and Scientific Reports.

In The Last Decade

Carmela Mannarelli

27 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Carmela Mannarelli Italy 13 996 793 619 385 23 27 1.1k
Laura Villani Italy 11 647 0.6× 508 0.6× 441 0.7× 280 0.7× 6 0.3× 29 753
Alem A. Belachew United States 7 950 1.0× 783 1.0× 581 0.9× 326 0.8× 24 1.0× 11 1.0k
Mythri Mudireddy United States 14 870 0.9× 808 1.0× 470 0.8× 254 0.7× 10 0.4× 25 948
Elisa Roncoroni Italy 7 587 0.6× 430 0.5× 385 0.6× 252 0.7× 16 0.7× 13 621
Ilyas Chachoua Belgium 9 619 0.6× 512 0.6× 471 0.8× 171 0.4× 24 1.0× 14 765
Christine Zoi Greece 6 336 0.3× 275 0.3× 226 0.4× 127 0.3× 9 0.4× 10 429
Alessandro M. Vannucchi Italy 9 355 0.4× 254 0.3× 256 0.4× 150 0.4× 7 0.3× 15 430
Chiara Cavalloni Italy 8 466 0.5× 302 0.4× 314 0.5× 144 0.4× 11 0.5× 15 524
Yoseph Elala United States 8 540 0.5× 440 0.6× 321 0.5× 243 0.6× 13 0.6× 14 641
Nabih Maslah France 11 298 0.3× 290 0.4× 217 0.4× 163 0.4× 5 0.2× 30 458

Countries citing papers authored by Carmela Mannarelli

Since Specialization
Citations

This map shows the geographic impact of Carmela Mannarelli's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Carmela Mannarelli with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Carmela Mannarelli more than expected).

Fields of papers citing papers by Carmela Mannarelli

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Carmela Mannarelli. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Carmela Mannarelli. The network helps show where Carmela Mannarelli may publish in the future.

Co-authorship network of co-authors of Carmela Mannarelli

This figure shows the co-authorship network connecting the top 25 collaborators of Carmela Mannarelli. A scholar is included among the top collaborators of Carmela Mannarelli based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Carmela Mannarelli. Carmela Mannarelli is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Guglielmelli, Paola, Giacomo Coltro, Francesco Mannelli, et al.. (2022). ASXL1 mutations are prognostically significant in PMF, but not MF following essential thrombocythemia or polycythemia vera. Blood Advances. 6(9). 2927–2931. 18 indexed citations
2.
Coltro, Giacomo, Francesco Mannelli, Giuseppe Gaetano Loscocco, et al.. (2022). Differential prognostic impact of cytopenic phenotype in prefibrotic vs overt primary myelofibrosis. Blood Cancer Journal. 12(8). 116–116. 11 indexed citations
3.
Mannelli, Francesco, Francesca Gesullo, Carmela Mannarelli, et al.. (2022). Diagnostic and therapeutic challenges in mast cell sarcoma. American Journal of Hematology. 98(3). 529–532. 1 indexed citations
4.
Scappini, Barbara, Francesco Mannelli, Andrea I. Pasquini, et al.. (2022). Venetoclax in Combination with Hypomethylating Agents or Low-Dose Cytarabine for Relapsed/Refractory Acute Myeloid Leukemia: A Retrospective Single-Centre Experience. Blood. 140(Supplement 1). 9008–9009. 2 indexed citations
5.
Loscocco, Giuseppe Gaetano, Paola Guglielmelli, Naseema Gangat, et al.. (2021). Clinical and molecular predictors of fibrotic progression in essential thrombocythemia: A multicenter study involving 1607 patients. American Journal of Hematology. 96(11). 1472–1480. 26 indexed citations
6.
Guglielmelli, Paola, Giuseppe Gaetano Loscocco, Carmela Mannarelli, et al.. (2021). JAK2V617F variant allele frequency >50% identifies patients with polycythemia vera at high risk for venous thrombosis. Blood Cancer Journal. 11(12). 199–199. 63 indexed citations
7.
Coltro, Giacomo, Paola Guglielmelli, Giada Rotunno, et al.. (2021). Mutation Landscape and Prognostic Correlates of ASXL1 Variants in Primary and Secondary Myelofibrosis. Blood. 138(Supplement 1). 2578–2578. 1 indexed citations
8.
Sordi, Benedetta, Francesco Mannelli, Boaz Palterer, et al.. (2021). Screening for Hereditary Alpha-Tryptasemia in Subjects with Systemic Mastocytosis (SM) and Non-SM Mast Cell Activation Symptoms. Blood. 138(Supplement 1). 1500–1500. 1 indexed citations
9.
Coltro, Giacomo, Giada Rotunno, Lara Mannelli, et al.. (2020). RAS/CBL mutations predict resistance to JAK inhibitors in myelofibrosis and are associated with poor prognostic features. Blood Advances. 4(15). 3677–3687. 52 indexed citations
10.
Salati, Simona, Roberta Zini, Niccolò Bartalucci, et al.. (2019). Calreticulin Ins5 and Del52 mutations impair unfolded protein and oxidative stress responses in K562 cells expressing CALR mutants. Scientific Reports. 9(1). 10558–10558. 30 indexed citations
11.
Guglielmelli, Paola, Niccolò Bartalucci, Elisa Contini, et al.. (2019). Involvement of RUNX1 Pathway Is a Common Event in the Leukemic Transformation of Chronic Myeloproliferative Neoplasms (MPNs). Blood. 134(Supplement_1). 2968–2968. 4 indexed citations
12.
Pacilli, Annalisa, Giada Rotunno, Carmela Mannarelli, et al.. (2018). Mutation landscape in patients with myelofibrosis receiving ruxolitinib or hydroxyurea. Blood Cancer Journal. 8(12). 122–122. 24 indexed citations
13.
Guglielmelli, Paola, Annalisa Pacilli, Giada Rotunno, et al.. (2017). Presentation and outcome of patients with 2016 WHO diagnosis of prefibrotic and overt primary myelofibrosis. Blood. 129(24). 3227–3236. 111 indexed citations
14.
Salati, Simona, Zelia Prudente, Valentina Pennucci, et al.. (2017). Calreticulin Affects Hematopoietic Stem/Progenitor Cell Fate by Impacting Erythroid and Megakaryocytic Differentiation. Stem Cells and Development. 27(4). 225–236. 14 indexed citations
15.
16.
Guglielmelli, Paola, Andrea Bisognin, Carmela Mannarelli, et al.. (2015). Small RNA Sequencing Uncovers New miRNAs and moRNAs Differentially Expressed in Normal and Primary Myelofibrosis CD34+ Cells. PLoS ONE. 10(10). e0140445–e0140445. 16 indexed citations
17.
Rotunno, Giada, Paola Guglielmelli, Annalisa Pacilli, et al.. (2015). Mutational Landscape of Patients with Myelofibrosis That Do Not Harbor Mutations in JAK2, MPL and Calreticulin Driver Genes. Blood. 126(23). 4091–4091. 3 indexed citations
18.
Guglielmelli, Paola, Flavia Biamonte, Giada Rotunno, et al.. (2014). Impact of mutational status on outcomes in myelofibrosis patients treated with ruxolitinib in the COMFORT-II study. Blood. 123(14). 2157–2160. 79 indexed citations
19.
Pennucci, Valentina, Roberta Zini, Ruggiero Norfo, et al.. (2013). Abnormal Expression Of WT1-As, MEG3 and ANRIL Long Non-Coding RNAs In Primary Myelofibrosis and Their Clinical Correlates. Blood. 122(21). 2845–2845. 1 indexed citations
20.
Bartalucci, Niccolò, Costanza Bogani, Serena Martinelli, et al.. (2013). The PI3K Specific Inhibitor BKM120 Results Effective and Synergizes With Ruxolitinib In Preclinical Models Of Myeloproliferative Neoplasms. Blood. 122(21). 1599–1599. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Laura Villani Breakdown of academic impact, for papers by Alem A. Belachew Breakdown of academic impact, for papers by Mythri Mudireddy Breakdown of academic impact, for papers by Elisa Roncoroni Breakdown of academic impact, for papers by Ilyas Chachoua Breakdown of academic impact, for papers by Christine Zoi Breakdown of academic impact, for papers by Alessandro M. Vannucchi Breakdown of academic impact, for papers by Chiara Cavalloni Breakdown of academic impact, for papers by Yoseph Elala Breakdown of academic impact, for papers by Nabih Maslah
Rankless by CCL
2026